Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epilepsy in the elderly.

I E Leppik1

  • 1MINCEP Epilepsy Care, 5775 Wayzata Boulevard, Suite 200, Minneapolis, MN 55416, USA.

Current Neurology and Neuroscience Reports
|March 20, 2002
PubMed
Summary

Epilepsy affects about 1.5% of older adults, twice the rate in younger people. Treating elderly epilepsy patients requires careful consideration of drug interactions due to altered metabolism and other health issues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory.

Epilepsy & behavior : E&B·2012
Same author

Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.

Journal of veterinary internal medicine·2012
Same author

Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.

Clinical pharmacology and therapeutics·2012
Same author

Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study.

Neurology·2010
Same author

Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy.

Neurology·2008
Same author

Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.

Journal of veterinary pharmacology and therapeutics·2008

Area of Science:

  • Geriatric Medicine
  • Neurology
  • Clinical Pharmacology

Background:

  • The prevalence of epilepsy is approximately 1.5% in individuals over 65, which is double the rate observed in younger adults.
  • Epilepsy treatment in the elderly population presents unique challenges.
  • These challenges include altered drug metabolism, the presence of multiple concurrent medical conditions, and the frequent use of concomitant medications.

Purpose of the Study:

  • To highlight the complexities of treating epilepsy in elderly patients.
  • To emphasize the critical importance of understanding drug interactions in this demographic.

Main Methods:

  • Review of existing literature on epilepsy in the elderly.
  • Analysis of pharmacokinetic and pharmacodynamic principles relevant to geriatric patients.
  • Examination of drug interaction profiles, including isoenzyme activity and protein binding.

Main Results:

  • Elderly patients exhibit altered drug metabolism, increasing susceptibility to adverse drug events.
  • Polypharmacy is common in this age group, significantly raising the risk of drug-drug interactions.
  • A comprehensive understanding of the isoenzyme profile and protein-binding characteristics of all prescribed medications is essential for safe and effective treatment.

Conclusions:

  • Effective management of epilepsy in older adults necessitates a thorough understanding of drug interactions.
  • Pharmacological management must account for age-related physiological changes and the patient's overall medical status.
  • Clinicians must possess detailed knowledge of drug metabolism and binding to optimize antiepileptic drug therapy in the elderly.

Related Experiment Videos